Long-term outcomes of surgical management of primary pulmonary myxoid sarcoma: A case study
Main Article Content
Keywords
Abstract
Primary pulmonary myxoid sarcoma (PPMS) is a very rare lung cancer. The exact mechanisms of PPMS are still unknown, possibly derived from mesenchymal cells. We report 4-year outcomes of a case with PPMS in the left upper lobe. A 30-year-old man who complained of phlegm cough. In March 2014, CT showed a mass measuring 27 × 29mm in the central left upper lobe. The patient underwent CT-guided percutaneous transthoracic needle biopsy of the tumor, which showed necrotic and inflammatory changes and the patient received no treatment. After one year, the tumor almost doubled in size (45 × 53mm) on chest CT. The tumor with the left upper lobe was surgically removed. Subsequent immunohistochemistry analysis of the sample confirmed the diagnosis of PPMS. Postoperative follow-up showed no sign of recurrence up to 4 years
Article Details
References
2. Prieto-Granada CN, Ganim RB, Zhang L et al (2017) Primary pulmonary myxoid sarcoma: A newly described entity-report of a case and review of the literature. Int J Surg Pathol 25(6): 518-525.
3. Thway K, Nicholson AG, Lawson K et al (2011) Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: A new tumor entity. Am J Surg Pathol 35(11): 1722-1732.
4. Matsukuma S, Hisaoka M, Obara K et al (2012) Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of literature. Pathol Int 62(12): 817-822.
5. Kim S, Song SY, Yun JS et al (2017) Primary pulmonary myxoid sarcoma located in interlobar fissure without parenchymal invasion. Thorac Cancer 8(5): 535-538.
6. Jeon YK, Moon KC, Park SH et al (2014) Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch 465(4): 453-461.
7. Travis WD, Brambilla E, Nicholson AG et al (2015) The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10(9): 1243-1260.